Gene Therapies for the Hemophilias

This publication has 27 references indexed in Scilit:

• Long-Term Persistence of Human Bone Marrow Stromal Cells Transduced with Factor VIII-Retroviral Vectors and Transient Production of Therapeutic Levels of Human Factor VIII in Nonmyeloablated Immunodeficient Mice
  Human Gene Therapy, 2000
• Sustained expression of human factor VIII in mice using a parvovirus-based vector
  Blood, 2000
• Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
  Nature Genetics, 2000
• Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector
  Blood, 2000
• Efficient lentiviral transduction of liver requires cell cycling in vivo
  Nature Genetics, 2000
• Adenovirus-Mediated Expression of Human Coagulation Factor IX in the Rhesus Macaque Is Associated With Dose-Limiting Toxicity
  Blood, 1999
• In Vivo Evaluation of an Adenoviral Vector Encoding Canine Factor VIII: High-Level, Sustained Expression in Hemophiliac Mice
  Human Gene Therapy, 1999
• Protein evolution by molecular breeding
  Current Opinion in Chemical Biology, 1999
• Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
  Gene Therapy, 1999
• Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa
  Proceedings of the National Academy of Sciences, 1997